Sign in

    Nan Fang

    Research Analyst at QX Capital

    Nan Fang is an Analyst at QX Capital, specializing in equity research within the technology and healthcare sectors. Fang covers a portfolio of publicly traded companies that includes industry leaders such as Alibaba, NetEase, and BeiGene, and has built a strong track record for providing actionable investment calls backed by data-driven analysis. With a career that began in 2016 at Citic Securities before joining QX Capital in 2022, Fang has established a reputation for thorough sector insight and was ranked in the top 25% of analysts by performance on platforms like TipRanks, reporting a 63% success rate and average annualized returns exceeding 11%. Fang holds FINRA Series 7 and Series 63 registrations and is recognized for rigorous research standards and transparent methodology.

    Nan Fang's questions to GreenTree Hospitality Group (GHG) leadership

    Nan Fang's questions to GreenTree Hospitality Group (GHG) leadership • Q1 2024

    Question

    Nan Fang of QX Capital inquired about GreenTree's dividend policy, the potential for a special dividend, the strategy for restaurant openings, and the company's expansion into higher-end hotel segments.

    Answer

    Executive Alex Xu confirmed that the company plans to resume its dividend policy, with a formal announcement expected next quarter, while special dividends will be evaluated based on cash position and growth needs. For the restaurant business, Xu outlined a strategy focused on profitability over scale, planning to open 45-50 new, smaller-footprint franchised stores by year-end. He also detailed the expansion in the mid-to-upscale hotel segment through brands like GreenTree Eastern and new boutique concepts to drive ADR growth.

    Ask Fintool Equity Research AI